secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (ZION)
CIK:        0000109380
Form:       8-K
Filed at:   2021-07-19T23:59:59+00:00
Accession:  0000109380-21-000216
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zions Q2 net earnings $345M, diluted EPS $2.08 vs $0.34 YoY; credit release of $123M
--------------------------------------------------------------------------------

- Net earnings $345M ($2.08 diluted EPS) vs $57M ($0.34) in Q2 2020; PPNR up 32%.
- Provision for credit losses negative $123M (release) vs positive $168M YoY; allowance 1.2% of loans ex-PPP.
- CET1 capital ratio 11.3% vs 10.2% at pandemic start; preferred stock redemption of $126M.
- Loans and leases $51.4B, down 7% (ex-PPP down 3%); deposits up 16% to $76.1B.
- SBIC investment in Recursion Pharma contributed $54M net unrealized gain ($0.25 per share).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109380/000010938021000216/0000109380-21-000216-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109380/000010938021000216/zion-20210719.htm
  HTML page:      https://secwatch.observer/filing/0000109380-21-000216

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer